# The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation

> **NCT02935998** · PHASE4 · UNKNOWN · sponsor: **Yang Fude** · enrollment: 1000 (estimated)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Ziprasidone

## Key facts

- **NCT ID:** NCT02935998
- **Lead sponsor:** Yang Fude
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2016-10-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02935998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02935998, "The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02935998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*